BUZZ-Sino Biopharmaceutical rises most in nearly 5 weeks on LaNova deal ** Sino Biopharmaceutical 1177.HK rises 4.3% to HK$3.41; set for biggest one-day pct gain since Oct. 18
** Co buys 4.91% stake in LaNova Medicines for 142 mln yuan ($19.6 mln), enters into agreement for LM-108, a monoclonal antibody for various solid tumour treatment currently at Phase II clinical stage, in Mainland China region
** Says further cooperations with LaNova for various innovative bispecific antibody and antibody-drug conjugates in its pipelines
** Hong Kong's healthcare index .HSCIH up 2.9%
** Stock down 5.8% YTD
($1 = 7.2418 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments